Univest
Univest
  • Markets

Alankit Analyst Review 2027: Profit Up 65% as Promoters Raise Stake to 59%

  • November 19, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Alankit Analyst Review 2027: Profit Up 65% as Promoters Raise Stake to 59%

Alankit Stock Snapshot (18 Nov 2026 close)

  • Current Market Price (CMP): ₹7.95
  • 52-Week High / Low: ₹11.67 / ₹6.00
  • Market Capitalisation: ₹240 crore
  • P/E Ratio vs Industry P/E: 10.4 vs 18.7
  • Latest Quarter (Q2 FY27) Revenue: ₹99.72 crore
  • Latest Quarter (Q2 FY27) Net Profit: ₹7.39 crore

Quick Answer: The Alankit analyst review 2027 finds no brokerage coverage as of November 2026. Q2 FY27 revenue rose about 16% to ₹99.72 crore, EBITDA rose about 59% to ₹14.31 crore and net profit rose about 65% to ₹7.39 crore. Promoter holding rose to about 59.1% from 54.2% over the year. FY26 revenue was ₹373.4 crore with profit of ₹20.9 crore. At ₹7.95, the stock trades at about 10.4 times earnings and 0.67 times book value, so the Alankit share price target 2027 question depends on steady profit growth.

The Alankit analyst review 2027 covers a Delhi-based company that provides e-governance and financial services, including identity and tax-related facilitation, depository and broking services and insurance broking. Readers searching for an Alankit share price target 2027 will not find a named brokerage figure, so results, ownership and valuation guide this review.

Alankit closed at ₹7.95 on 18 November 2026, about 32% below its 52-week high of ₹11.67 and about 33% above its low of ₹6. This Alankit analyst review 2027 covers the September quarter and the Alankit stock outlook 2027.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Analysts Say in the Alankit Analyst Review 2027
  • Q2 FY27 Results in the Alankit Analyst Review 2027
  • How Alankit Makes Money
  • Growth Triggers in the Alankit Analyst Review 2027
  • Key Risks in the Alankit Analyst Review 2027
  • Alankit Analyst Review 2027: Stock at a Glance
  • Shareholding Trend
  • What to Watch After the Alankit Analyst Review 2027
  • Final Word on the Alankit Analyst Review 2027
  • Frequently Asked Questions
    • What does the Alankit analyst review 2027 show?
    • Is there an Alankit share price target 2027 from brokerages?
    • What does Alankit do?
    • Why did Alankit promoters raise their stake?
    • Is Alankit stock undervalued based on the Alankit analyst review 2027?
    • What risks does the Alankit analyst review 2027 highlight?
    • What should investors track after the Alankit analyst review 2027?

What Analysts Say in the Alankit Analyst Review 2027

Brokerage Rating Target Price Date
No verified coverage Not available Not available As of November 2026

No brokerage covers Alankit, and institutions hold less than 0.5% of the company. With a market value of about ₹240 crore and a share price below ₹10, it sits outside research coverage.

The stock trades at about 10.4 times trailing earnings, below the industry level of about 18.7, and at about 0.67 times book value of ₹11.79 per share. This Alankit analyst review 2027 weighs that against uneven profits and weak cash flow.

Q2 FY27 Results in the Alankit Analyst Review 2027

Quarter Revenue EBITDA Net Profit
Sep 2026 (Q2 FY27) ₹99.72 crore ₹14.31 crore ₹7.39 crore
Jun 2026 (Q1 FY27) ₹81.72 crore ₹10.41 crore ₹5.32 crore
Mar 2026 (Q4 FY26) ₹104.12 crore ₹7.74 crore ₹2.39 crore
Dec 2025 (Q3 FY26) ₹75.94 crore ₹10.01 crore ₹8.03 crore
Sep 2025 (Q2 FY26) ₹85.67 crore ₹9.00 crore ₹4.49 crore

Revenue rose about 16% from a year ago and about 22% from the June quarter. EBITDA rose about 59% to ₹14.31 crore, lifting the EBITDA margin to about 14.4% from about 10.5%. Net profit rose about 65% to ₹7.39 crore.

The quarter had the highest EBITDA in the table. For this Alankit analyst review 2027, margin improvement is the main story, after a weak March quarter.

How Alankit Makes Money

Alankit earns fees from a mix of government-linked and financial services.

  • E-governance services: facilitation work for identity, tax and other government processes.
  • Depository and broking: demat and trading services for investors.
  • Insurance broking: distribution of insurance products.
  • Other services: related financial and technology services for clients.

Revenue grew from about ₹247.6 crore in FY24 to ₹319.4 crore in FY25 and ₹373.4 crore in FY26, while profit stayed near ₹21 crore to ₹22 crore each year. Operating cash flow swung to a negative ₹22.1 crore in FY26 from a positive ₹49.2 crore in FY25. Those numbers frame this Alankit analyst review 2027.

Revenue has grown at a healthy pace, but profit has not kept up, which means margins shrank over that period. The September quarter is the first clear sign of margins turning higher, which is why it matters more than the revenue growth.

Service businesses linked to government contracts can see lumpy revenue, because contract renewals and billing cycles do not follow even quarters. That explains why revenue moved between about ₹76 crore and ₹104 crore over five quarters.

The promoter stake increase is notable. Promoter holding rose to about 59.1% in October 2026 from about 54.2% in December 2025, led by Alankit Brands at 32.4%. Promoters buying more shares is often read as a sign of confidence in the business.

Over the last four quarters, profit totals about ₹23.1 crore, slightly above the FY26 figure. If the September margin holds, FY27 profit could rise meaningfully, though the weak cash flow in FY26 is a reason for caution.

Debt is not a major concern, with debt to equity of about 0.20. The bigger balance sheet question is working capital, because service businesses that bill government-linked clients can wait a long time for payment. A return to positive operating cash flow, as in FY25, would show that the higher profit in FY27 is turning into cash rather than sitting in receivables, which would strengthen the case for the stock moving closer to book value.

Growth Triggers in the Alankit Analyst Review 2027

  • Margin expansion: EBITDA margin up to about 14.4%.
  • Profit growth: Q2 FY27 profit up about 65%.
  • Revenue growth: about 23% a year from FY24 to FY26.
  • Promoter buying: stake up about 5 points to 59.1%.
  • Low valuation: below book value, feeding the Alankit share price target 2027 debate.

Key Risks in the Alankit Analyst Review 2027

  • Negative cash flow: about ₹22.1 crore outflow from operations in FY26.
  • Flat annual profit: around ₹21 crore for three years.
  • Lumpy revenue: contract and billing timing.
  • Low returns: return on equity of about 6.7%.
  • Penny-stock risk: a share price below ₹10, a caution in the Alankit analyst review 2027.

Compare Alankit With Other Financial Services Stocks on the Univest Screener

Alankit Analyst Review 2027: Stock at a Glance

Metric Value
Share Price (18 Nov 2026 close) ₹7.95
52-Week High / Low ₹11.67 / ₹6.00
Market Capitalisation ₹240 crore
P/E (TTM) 10.4
Price to Book 0.67
Book Value per Share ₹11.79
Return on Equity 6.7%
Debt to Equity 0.20
EPS (TTM) ₹0.76
FY26 Revenue / Net Profit ₹373.4 crore / ₹20.9 crore

The P/E of about 10 and price to book value of about 0.67 are low. In this Alankit analyst review 2027, low returns and weak cash flow explain why the stock trades below book.

Shareholding Trend

Holder Dec 2025 Oct 2026 Change
Promoters 54.15% 59.12% Up 4.97 points
Foreign Investors (FII) 0.44% 0.34% Down 0.10 points
Domestic Institutions (DII) 0.01% 0.04% Flat
Public 45.40% 40.49% Down 4.91 points

The promoter group holds about 59.1%, led by Alankit Brands at 32.4% and Alka Agarwal at 10.9%. The rise of about 5 points is a positive signal in the Alankit analyst review 2027.

Univest iOS App

Univest Android App

What to Watch After the Alankit Analyst Review 2027

  • Margins: EBITDA margin holding above 12%.
  • Cash flow: a return to positive operating cash flow.
  • FY27 profit: growth above the ₹21 crore level of recent years.
  • Promoter activity: any further stake increase.
  • Coverage: any research note would give an Alankit share price target 2027 reference.

Final Word on the Alankit Analyst Review 2027

The Alankit analyst review 2027 shows a services company with rising revenue, a sharp margin improvement in Q2 FY27 and promoters adding to their stake. Weak cash flow and flat annual profit are the main concerns.

The Alankit stock outlook 2027 depends on margins, cash generation and profit growth. Univest does not give a buy or sell call.

Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions

What does the Alankit analyst review 2027 show?

It shows strong profit growth. Q2 FY27 revenue rose about 16% to ₹99.72 crore and net profit rose about 65% to ₹7.39 crore. EBITDA margin improved to about 14.4%.

Is there an Alankit share price target 2027 from brokerages?

No brokerage covers Alankit as of November 2026. The stock closed at ₹7.95 on 18 November 2026. Book value per share is about ₹11.79.

What does Alankit do?

Alankit provides e-governance and financial services. These include identity and tax-related facilitation, depository and broking services and insurance broking. FY26 revenue was about ₹373.4 crore.

Why did Alankit promoters raise their stake?

Promoter holding rose to about 59.1% in October 2026 from about 54.2% in December 2025. Alankit Brands holds about 32.4%. Promoter buying is often read as a sign of confidence.

Is Alankit stock undervalued based on the Alankit analyst review 2027?

The P/E of about 10.4 is below the industry P/E of about 18.7. Price to book is about 0.67. Low return on equity and weak cash flow explain the discount.

What risks does the Alankit analyst review 2027 highlight?

The main risks are negative cash flow, flat annual profit and lumpy revenue. FY26 operating cash flow was about minus ₹22.1 crore. The stock trades below ₹10.

What should investors track after the Alankit analyst review 2027?

Track whether EBITDA margin stays above 12% and cash flow turns positive. Watch FY27 profit against about ₹21 crore in past years. Further promoter buying also matters.



2027 Alankit Analyst Review E-Governance and Financial Services
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply